Suchergebnisse - "Yuan, Shuofeng"

PubPharm (11)

1

P21-activated kinase 1 (PAK1)-mediated cytoskeleton rearrangement promotes SARS-CoV-2 entry and ACE2 autophagic degradation

enthalten in: Signal transduction and targeted therapy | 2023

von Liu, M. | Lu, B. | Li, Y. | +16

2

Key mutations on spike protein altering ACE2 receptor utilization and potentially expanding host range of emerging SARS-CoV-2 variants

enthalten in: Journal of medical virology | 2023

von Wang, Q. | Ye, S. | Zhou, Z. | +6

3

Control of SARS-CoV-2 infection by MT1-MMP-mediated shedding of ACE2

enthalten in: Nature communications | 2022

von Guo, X. | Cao, J. | Cai, J. | +19

4

A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo

enthalten in: Cell reports. Medicine | 2022

von Chan, J. | Oh, Y. | Yuan, S. | +37

5

Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo

enthalten in: Cell research | 2022

von Li, M. | Ye, Z. | Tang, K. | +10

6

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron

enthalten in: Nature | 2022

von Shuai, H. | Chan, J. | Hu, B. | +24

CommentIn: Signal Transduct Target Ther. 2022 Jul 5;7(1):211. - PMID 35790725

7

COVID-19 in Joint Ageing and Osteoarthritis : Current Status and Perspectives

enthalten in: International journal of molecular sciences | 2022

von Lauwers, M. | Au, M. | Yuan, S. | +1

8

Emerging SARS-CoV-2 variants expand species tropism to murines

enthalten in: EBioMedicine | 2021

von Shuai, H. | Chan, J. | Yuen, T. | +28

9

Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity

enthalten in: Science advances | 2021

von Chu, H. | Shuai, H. | Hou, Y. | +22

10

Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies

enthalten in: Cell host & microbe | 2021

von Zhou, D. | Chan, J. | Zhou, B. | +25